Immuneering (IMRX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access IMRX Annual Balance Sheets →
This page allows investors to track Immuneering's balance sheet development across multiple reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent41.32
Available-for-sale Securities, Debt Securities, Current MA0.41
Cash & Short-term Investments41.00
Other Current Assets108.17
Prepaid Expense And Other Assets Current8.09
Total Current Assets157.99
Equipment/Property/Plant Net2.45
Goodwill net6.69
Intangible Assets0.31
Other Assets, Noncurrent34.62
Debt Securities Available For Sale Excluding Accrued Interest Current109.37
Debt Securities Available For Sale Excluding Accrued Interest Noncurrent41.95
Operating Lease Right Of Use Asset3.23
Total Assets202.06
Liabilities
Accounts Payable, Current AC3.38
Accrued Liabilities, Current AC4.09
Other Liabilities, Current0.64
Total Current Liabilities8.12
Total Long-term Debt0.00
Other liabilities, Noncurrent3.20
DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent-
Operating Lease Liability Current0.41
Total Liabilities11.32
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock502.13
Retained Earnings / Accumulated Deficit-311.05
Accumulated Other Comprehensive Income-0.41
Other Equity-0.41
Common Stockholder's Equity190.74
Total Stockholder's Equity190.74
Liabilities & Stockholder's Equity202.06
4 historic quarters locked

Sign in to unlock the full Immuneering balance sheet history.

About Immuneering Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001790340-26-000091

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.